Items where Author is "Gue, Ying X."
Number of items: 25.
Article
Impact of Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy on Endogenous Fibrinolysis in Acute Coronary Syndrome: The VaLiDate-R study. (2024)
Ying X. Gue,
Vassilios Memtsas,
Rahim Kanji,
David Wellsted,
Amanda Busby,
Megan Smith,
Enric Vilar,
Alisdair Ryding,
Deepa J. Arachchillage
and
Diana Gorog
Biomarkers of Thrombotic Status Predict Spontaneous Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction. (2023)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas,
Neil H. Spencer
and
Diana Gorog
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction. (2022)
Rahim Kanji,
Ying X. Gue,
Mohamed F. Farag,
Neil H. Spencer,
Nicola J. Mutch
and
Diana A. Gorog
Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients? (2022)
Ying X. Gue,
Diana A. Gorog
and
Gregory Y.H. Lip
Antithrombotic in atrial fibrillation and coronary artery disease – Does less mean more? (2022)
Ying X. Gue,
Diana Gorog
and
Gregory Y H Lip
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: An European and Asia-Pacific Expert Consensus Paper. (2022)
Diana Gorog,
Ying X. Gue,
Tze-Fan Chao,
Laurent Fauchier,
Jose Luis Ferreiro,
Kurt Huber,
Stavros V Konstantinidis,
Deirdre A Lane,
Francisco Marin,
Jonas Oldgren,
Tatjana Potpara,
Vanessa Roldan,
Andrea Rubboli,
Dirk Sibbing,
Hung-Fat Tse,
Gemma Vilahur
and
Gregory Y H Lip
Spontaneous reperfusion in patients with transient ST-elevation myocardial infarction - prevalence, importance and approaches to management. (2021)
Mohamed Farag,
Marta Peverelli,
Nikolaos Spinthakis,
Ying X. Gue,
Mohaned Egred
and
Diana Gorog
Fibrinolysis in platelet thrombi. (2021)
Rahim Kanji,
Ying X. Gue,
Vassilios Memtsas
and
Diana Gorog
Assessment of endogenous fibrinolysis in clinical using novel tests - Ready for clinical roll-out? (2021)
Ying X. Gue,
Wern Yew Ding,
Gregory Y H Lip
and
Diana Gorog
Thrombotic complications in 2,928 patients with COVID-19 treated in intensive care: a systematic review. (2021)
William Jenner,
Rahim Kanji,
Saeed Mirsadraee,
Ying X. Gue,
Susanna Price,
Sanjay Prasad
and
Diana Gorog
Non-Vitamin K Antagonist Oral Anticoagulants versus Warfarin for Patients with Left Ventricular Thrombus: A Systematic Review and Meta-analysis. (2021)
Ying X. Gue,
Nikolaos Spinthakis,
Mohaned Egred,
Diana Gorog
and
Mohamed Farag
Precision treatment in ACS – role of assessing fibrinolysis. (2021)
Ying X. Gue,
Young-Hoon Jeong,
Mohamed Farag,
Nikolaos Spinthakis
and
Diana Gorog
Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. (2020)
Ying X. Gue,
Maria Tennyson,
Jovia Gao,
Shuhui Ren,
Rahim Kanji
and
Diana A. Gorog
Angiotensin Converting Enzyme 2 may mediate disease severity in COVID-19. (2020)
Ying X. Gue,
Rahim Kanji
and
Diana Gorog
MINOCA presenting with STEMI- a review of incidence, aetiology, assessment and treatment. (2020)
Ying X. Gue,
Rahim Kanji,
Sabiha Gati
and
Diana Gorog
Fatal heart block from intentional yew tree (Taxus baccata) ingestion: a case report. (2019)
Natasha G,
Mark Chan,
Ying X. Gue
and
Diana Gorog
MINOCA presenting with STEMI – incidence, aetiology and outcome in a contemporaneous cohort. (2019)
Ying X. Gue,
Natasha Corballis,
Alisdair Ryding,
Juan Carlos Kaski
and
Diana Gorog
Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction. (2019)
Krishma Adatia,
Mohamed Farag,
Ying X. Gue,
Manivannan Srinivasan
and
Diana Gorog
Apixaban Enhances Endogenous Fibrinolysis in Patients with Atrial Fibrillation. (2019)
Nikolaos Spinthakis,
Ying X. Gue,
Mohamed Farag,
Manivannan Srinivasan,
David Wellsted,
Gregory Y H Lip,
Deepa RJ Arachchillage
and
Diana Gorog
A case of repetitive myocardial infarction with unobstructed coronaries due to Churg-Strauss syndrome. (2019)
Ying X. Gue,
Sanjay Prasad,
David Isenberg
and
Diana A. Gorog
Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019)
Mohamed Farag,
Nikolaos Spinthakis,
Ying X. Gue,
Manivannan Srinivasan,
Keith Sullivan,
David Wellsted
and
Diana A. Gorog
A rare cause of myocardial infarction with non-obstructive coronary arteries-case report of ST-segment elevation myocardial infarction caused by a mediastinal mass. (2018)
Ying X. Gue,
Majid Anwar
and
Diana A. Gorog